Growth Metrics

Lisata Therapeutics (LSTA) Asset Utilization Ratio (2016 - 2025)

Lisata Therapeutics (LSTA) has disclosed Asset Utilization Ratio for 11 consecutive years, with 0.04 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Asset Utilization Ratio changed N/A year-over-year to 0.04, compared with a TTM value of 0.04 through Sep 2025, changed N/A, and an annual FY2024 reading of 0.02, changed N/A over the prior year.
  • Asset Utilization Ratio was 0.04 for Q3 2025 at Lisata Therapeutics, up from 0.04 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.04 in Q3 2025 and bottomed at 0.0 in Q1 2023.
  • Average Asset Utilization Ratio over 3 years is 0.02, with a median of 0.03 recorded in 2025.